Efficacy and safety of nivolumab monotherapy in metastatic urothelial cancer (mUC): Results from the phase VII CheckMate 032 study.

被引：26

作者：

Sharma, Padmanee

Bono, Petri

Kim, Joseph W.

Spiliopoulou, Pavlina

Calvo, Emiliano

Pillai, Rathi Narayana

Ott, Patrick Alexander

De Braud, Filippo G.

Morse, Michael A.

Le, Dung T.

Jaeger, Dirk

Chan, Emily

Harbison, Christopher T.

Lin, Chen-Sheng

Tschaika, Marina

Azrilevich, Alex

Rosenberg, Jonathan

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Helsinki Univ Hosp, Ctr Comprehens Canc, Helsinki, Finland

[3] Yale Univ, Yale Canc Ctr, New Haven, CT USA

[4] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland

[5] START Madrid, Ctr Integral Oncol Clara Campal, Madrid, Spain

[6] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

[7] Dana Farber Canc Inst, Boston, MA 02115 USA

[8] Fdn IRCCS Ist Nazl Tumori, Milan, Italy

[9] Duke Univ, Med Ctr, Durham, NC USA

[10] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA

[11] Univ Hosp Heidelberg, Natl Ctr Tumor Dis, Heidelberg, Germany

[12] Vanderbilt Univ, Med Ctr, Nashville, TN USA

[13] Bristol Myers Squibb, Princeton, NJ USA

[14] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

来源：

关键词：

D O I：

10.1200/JCO.2016.34.15_suppl.4501

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4501

引用

页数：2